Integrated Near-Infrared Spectroscopy and Hemodynamic Monitoring for Cerebral Autoregulation in Post-Cardiac Arrest Care Neuroprognostication
1 other identifier
observational
60
1 country
1
Brief Summary
Neurological outcome is the primary outcome for post-cardiac arrest patients. Hypoxic-ischemic brain injury is a key element in post-cardiac arrest syndrome, and remains the leading cause of mortality and morbidity in post-cardiac arrest patients. In patients with hypoxic-ischemic brain injury, impaired cerebral autoregulation makes cerebral blood flow highly vulnerable to blood pressure fluctuations, which might trigger secondary brain injuries. Although the pressure reactivity index (PRx) calculated via invasive intracranial pressure (ICP) monitoring is considered the gold standard for assessing cerebral autoregulation, its clinical application in post-cardiac arrest patients is limited due to invasive risks. Alternatively, cerebral near-infrared spectroscopy (NIRS) combined with hemodynamic monitoring offers a non-invasive approach to measure the cerebral oxygenation index (COx). However, its consistency with invasive methods and its accuracy in post-cardiac arrest care warrant further validation. The aim of this study is to assess cerebral autoregulation via COx calculated with NIRS and hemodynamic parameters in post-cardiac arrest patients, and to analyze the impact of this index on neurological outcomes. The further goal is to estimate optimal mean arterial pressure (MAPopt) and subsequently establish personalized post-resuscitation blood pressure targets.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2027
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2026
CompletedFirst Posted
Study publicly available on registry
October 15, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2029
Study Completion
Last participant's last visit for all outcomes
December 31, 2029
October 15, 2026
October 1, 2026
2.6 years
October 5, 2026
October 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Neurological Outcome
Cerebral Performance Category Scale (1-5), higher scores mean a worse outcome
up to 1 year
Eligibility Criteria
post-cardiac arrest patients admitted to ICU
You may qualify if:
- non-traumatic cardiac arrest
- admitted to ICU
- unable to follow verbal instructions (GCS: motor \<=5)
You may not qualify if:
- traumatic cardiac arrest
- pregnancy
- cognitive impairment before cardiac arrest (CPC scale \>=3)
- severe peripheral artery diseases
- Raynaud's syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dean-An Ling
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2026
First Posted
October 15, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
July 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
October 15, 2026
Record last verified: 2026-10